Research AboutOfferDocumentationLoginBook a demo
ResearchAboutOfferLoginBook a demo

NeoStrata

Ownership
Private
Employees
~111
Therapeutic Areas
Dermatology
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeTopical formulation

NeoStrata General Information

NeoStrata is a leader in dermatologist-developed skincare, pioneering the use of alpha hydroxy acids (AHAs), polyhydroxy acids (PHAs), and other patented skin-renewal technologies validated in numerous scientific publications. Their products are widely used and recognized for efficacy in anti-aging, hyperpigmentation, and various dermatological conditions[1][2][4].

Contact Information

Website
Primary Industry
Biotech
Corporate Office
Skillman, New Jersey
United States

Drug Pipeline

No pipeline data available

For full access to NeoStrata's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

NeoStrata Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view NeoStrata's complete valuation and funding history, request access »

NeoStrata Financial Metrics

See full profile
Book a demo
OverviewDrug PipelineTechnologiesPartnershipsFundingCompetitorsAnalysisPatentsLicensing Deals